Application of CYP3A4<i>in vitro</i>data to predict clinical drug–drug interactions; predictions of compounds as objects of interaction

Abstract

The current study demonstrated that the use of rhCYPs with SIMCYP provides a robust in vitro system for predicting the likelihood and magnitude of changes in clinical exposure of compounds as a consequence of CYP3A4 inhibition by a concomitantly administered drug.